Table. Confirmed Cases of Enterovirus-Associated Fulminant Hepatitis in Association With Anti-CD20 Agents.

Source, Year	Anti-CD20 Agent	Patient, No.	Indication for Anti-CD20 Agent	Enterovirus-Associated Disease
				Clinical Presentation	Type of Enterovirus Identified	Diagnosis	Treatment for Enteroviral Infection	Outcome
Lefterova et al,1 2013	Rituximab	1	B-cell non-Hodgkin lymphoma	Meningo-encephalitis and fulminant hepatitis	Echovirus 18	Real-time polymerase chain reaction in cerebrospinal fluid, plasma, and liver tissue	Plasmapheresis	Death
Morgan et al,2 2015	Rituximab	1	Follicular lymphoma	Fulminant hepatitis	Echovirus 9	Real-time polymerase chain reaction in plasma and liver tissue	Intravenous IgG	Recovery with sequelae (memory loss and fatigue)
Bajema et al,3 2017	Rituximab	1	Nephrotic syndrome with minimal change disease	Meningo-encephalitis and fulminant hepatitis	Echovirus 9	Real-time polymerase chain reaction in plasma and liver tissue	None	Death